WikiTrademarks - Search, analyse, and monitor trademark applications.

Serial Number

73814395

Filing Date

24 Jul 1989

Registration Number

1621967

Registration Date

13 Nov 1990

Mark Drawing Code

1

Classifications

Declare the trademark use of AMGEN on the blockchain with WikiTrademarks.io.

First use of AMGEN anywhere

AMGEN was first used on 31 Mar 1984 for the primary classification of goods and services, international, 005 (Pharmaceuticals)

First use in commerce

There is no first use of this trademark in commerce detected yet.

Status Code

6

International Code

005

US Codes

005; 006; 018; 044; 046; 051; 052

First use of AMGEN anywhere

AMGEN was first used on 01 Jan 1981 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)

First use in commerce

There is no first use of this trademark in commerce detected yet.

Status Code

6

International Code

042

US Codes

100; 101

Timothy J. Gaul

Amgen Inc.

One Amgen Center Drive

Trademark Operations MS 28-5-A

Amgen v. Sanofi: Seven Months In, Has Anything About Patent Enablement Changed? Tweet this

Amgen is the Answer to Alice Tweet this

This week on MIP: Amgen biosimilar ban, new UPC judges Tweet this

SCOTUS Ushers in New Era of Enablement Law in Amgen Ruling Tweet this

The Truth Leaks Out: Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments Tweet this

What I’ll Be Watching for in the Amgen Oral Arguments Tweet this

Amgen Reply Brief Addresses Mischaracterizations by Sanofi, U.S. Government on Proper Enablement Inquiry for Genus Claims Tweet this

Amici Filings in Amgen Encourage the Supreme Court to Correct the Federal Circuit’s ‘Unworkable’ Enablement Standard Tweet this

Juno Asks Supreme Court to Reconsider Denial of Petition on Section 112 Question in Light of Amgen Review Tweet this

SCOTUS Takes on Scope of Enablement Inquiry in Amgen v. Sanofi: Implications for Pharma/ Biotech and Beyond Tweet this

Supreme Court Grants Two IP Cases, Including Amgen v. Sanofi on Enablement Tweet this

Amgen Says Solicitor General’s ‘Disagreement With Everyone’ Further Supports SCOTUS Review of Legal Standard for Enablement Tweet this

Other Barks & Bites for Friday, October 7: OSTP Publishes AI Bill of Rights Blueprint, Amgen Files Supplement Brief on Enablement Appeal, and Longtime Register of Copyrights Peters Passes Away Tweet this

CAFC Denies Amgen Petition to Reconsider Enablement Test for Biotech Patents Tweet this

Log in to edit this.